Evidence map›Paper›PMID 19817443›Full record

ArticleJournal of the American Chemical Society2009

Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation.

Peter Panizzi, Matthias Nahrendorf, Moritz Wildgruber, Peter Waterman, Jose-Luiz Figueiredo, Elena Aikawa, Jason McCarthy, Ralph Weissleder, Scott A Hilderbrand

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 178 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Fluorescent Biosensors Based on Silicon Nanowires.Nanomaterials (Basel, Switzerland) · 2021
    Review
  8. Different Approaches to Develop Nanosensors for Diagnosis of Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  9. An activatable PET imaging radioprobe is a dynamic reporter of myeloperoxidase activity in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Nanoimaging in cardiovascular diseases: Current state of the art.The Indian journal of medical research · 2015
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Peter PanizziCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, 185 Cambridge St., Boston, Massachusetts 02114, USA.
Matthias Nahrendorf
Moritz Wildgruber
Peter Waterman
Jose-Luiz Figueiredo
Elena Aikawa
Jason McCarthy
Ralph Weissleder
Scott A Hilderbrand
Massachusetts General Hospital · USCenter for Systems Biology · USHarvard University · US

Funding

Translational Program of Excellence in NanotechnologyU01HL080731 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2005 to 2009
$14.9M
Small Animal Imaging Resource GrantR24CA092782 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, RALPH · 2001 to 2006
$4.2M
Integrated FMT approaches for biomolecular measurementsR01EB006432 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2006 to 2013
$3.0M
Pathobiology of Staphyloccocus areus EndocarditisR00HL094533 · NHLBI · AUBURN UNIVERSITY AT AUBURN · PI PANIZZI, PETER ROLF · 2011 to 2013
$719k
NCI NIH HHS R24 CA092782NCI NIH HHS R24-CA92782NHLBI NIH HHS R00 HL094533NHLBI NIH HHS U01 HL080731NHLBI NIH HHS U01-HL080731NIBIB NIH HHS R01 EB006432
6 · The paper itself

Abstract

The current lack of suitable probes has limited the in vivo imaging of reactive oxygen/nitrogen species (ROS/RNS). ROS/RNS are often generated by ischemia-induced inflammation; defining the extent of tissue involvement or ROS/RNS-related damage would have a significant clinical impact. We present the preparation and demonstration of a fluorogenic sensor for monitoring peroxynitrite (ONOO(-)) and myeloperoxidase (MPO) mediated hypochlorous acid (HOCl/OCl(-)) production. The sensor consists of a long circulating biocompatible nanoparticle that targets phagocytic cells in vivo and is coated with approximately 400 quenched oxazine fluorophores that are released by reaction with HOCl or ONOO(-) but are stable toward oxidants such as hydroxyl radical, hydrogen peroxide, and superoxide. MPO-dependent probe activation is chloride ion dependent and is negated in flow cytometry studies of MPO inhibitor treated neutrophils. Fluorescence reflectance imaging and microscopic fluorescence imaging in mouse hearts after myocardial infarction showed probe release into neutrophil-rich ischemic areas, making this ROS/RNS sensor a novel prognostic indicator.

Indexed as

NanoparticlesAnimalsHypochlorous AcidMagnetic Resonance SpectroscopyMiceMice, Inbred C57BLMyocardiumOxazinesPeroxynitrous AcidReactive Nitrogen SpeciesReactive Oxygen SpeciesHypochlorous AcidOxazinesPeroxynitrous AcidReactive Nitrogen SpeciesReactive Oxygen Species

Identifiers

PMID19817443
PMCPMC2773134
OpenAlexW1977242080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.